
Eric E. Silverman
Examiner (ID: 2294)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618, 1615 |
| Total Applications | 298 |
| Issued Applications | 111 |
| Pending Applications | 2 |
| Abandoned Applications | 185 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 10/048732 | Temperature sensitive polymers | Jun 12, 2002 | Abandoned |
| 10/130541 | Polyion complex micelles of core/shell structure | May 16, 2002 | Abandoned |
Array
(
[id] => 6792963
[patent_doc_number] => 20030088307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Potent coatings for stents'
[patent_app_type] => new
[patent_app_number] => 10/150909
[patent_app_country] => US
[patent_app_date] => 2002-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9354
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088307.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150909 | Potent coatings for stents | May 15, 2002 | Abandoned |
Array
(
[id] => 6724645
[patent_doc_number] => 20030206957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Orally administered medicament delivery systems'
[patent_app_type] => new
[patent_app_number] => 10/138118
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3932
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20030206957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138118 | Orally administered medicament delivery systems | May 5, 2002 | Abandoned |
Array
(
[id] => 6756405
[patent_doc_number] => 20030004182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency'
[patent_app_type] => new
[patent_app_number] => 10/131556
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6993
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20030004182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10131556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/131556 | Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency | Apr 22, 2002 | Issued |
Array
(
[id] => 6813179
[patent_doc_number] => 20030072729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Simethicone as weight gain enhancer'
[patent_app_type] => new
[patent_app_number] => 10/122498
[patent_app_country] => US
[patent_app_date] => 2002-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12033
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10122498
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/122498 | Simethicone as weight gain enhancer | Apr 14, 2002 | Abandoned |
Array
(
[id] => 6658245
[patent_doc_number] => 20030078266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Reconstitutable parenteral composition'
[patent_app_type] => new
[patent_app_number] => 10/113281
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11754
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20030078266.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113281 | Reconstitutable parenteral composition | Mar 31, 2002 | Issued |
Array
(
[id] => 6729681
[patent_doc_number] => 20030185871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Bone replacement materials utilizing bioabsorbable liquid polymers'
[patent_app_type] => new
[patent_app_number] => 10/112554
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8627
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112554 | Bone replacement materials utilizing bioabsorbable liquid polymers | Mar 28, 2002 | Issued |
Array
(
[id] => 806442
[patent_doc_number] => 07419677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-02
[patent_title] => 'Treatment device and method of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/107410
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 23
[patent_no_of_words] => 5264
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/419/07419677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107410 | Treatment device and method of using the same | Mar 27, 2002 | Issued |
Array
(
[id] => 243322
[patent_doc_number] => 07589056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Agent for the prevention and treatment of sexually transmitted diseases-I'
[patent_app_type] => utility
[patent_app_number] => 10/472439
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9500
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472439 | Agent for the prevention and treatment of sexually transmitted diseases-I | Mar 27, 2002 | Issued |
Array
(
[id] => 6829290
[patent_doc_number] => 20030180348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Transcellular drug delivery system'
[patent_app_type] => new
[patent_app_number] => 10/102970
[patent_app_country] => US
[patent_app_date] => 2002-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6279
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102970
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102970 | Transcellular drug delivery system | Mar 21, 2002 | Abandoned |
Array
(
[id] => 101455
[patent_doc_number] => 07727539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement'
[patent_app_type] => utility
[patent_app_number] => 10/469617
[patent_app_country] => US
[patent_app_date] => 2002-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3503
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469617 | Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement | Mar 13, 2002 | Issued |
Array
(
[id] => 6864834
[patent_doc_number] => 20030190360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment'
[patent_app_type] => new
[patent_app_number] => 10/099462
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20171
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099462
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099462 | Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment | Mar 12, 2002 | Abandoned |
Array
(
[id] => 6178221
[patent_doc_number] => 20020156134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Method and use of alpha-amino-beta-mercapto-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage'
[patent_app_type] => new
[patent_app_number] => 10/093974
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6690
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10093974
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/093974 | Method and use of alpha-amino-beta-mercapto-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage | Mar 6, 2002 | Abandoned |
Array
(
[id] => 6906630
[patent_doc_number] => 20050102025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Plasma surface graft process for reducing thrombogenicity'
[patent_app_type] => utility
[patent_app_number] => 10/468149
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11499
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20050102025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468149
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468149 | Plasma surface graft process for reducing thrombogenicity | Feb 27, 2002 | Abandoned |
Array
(
[id] => 456928
[patent_doc_number] => 07244797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Organic domain/inorganic domain complex materials and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/467485
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 34173
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467485 | Organic domain/inorganic domain complex materials and use thereof | Feb 7, 2002 | Issued |
Array
(
[id] => 7183133
[patent_doc_number] => 20050191354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent'
[patent_app_type] => utility
[patent_app_number] => 10/466619
[patent_app_country] => US
[patent_app_date] => 2002-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2141
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466619 | Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent | Jan 20, 2002 | Abandoned |
Array
(
[id] => 270222
[patent_doc_number] => 07563456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Process for preparation of programmed liberation composition with venlafaxine and the resulting product'
[patent_app_type] => utility
[patent_app_number] => 10/476714
[patent_app_country] => US
[patent_app_date] => 2002-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2334
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563456.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476714 | Process for preparation of programmed liberation composition with venlafaxine and the resulting product | Jan 2, 2002 | Issued |
Array
(
[id] => 606155
[patent_doc_number] => 07153520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'Composition for sustained delivery of hydrophobic drugs and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/416980
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6372
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10416980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/416980 | Composition for sustained delivery of hydrophobic drugs and process for the preparation thereof | Dec 6, 2001 | Issued |
Array
(
[id] => 6855721
[patent_doc_number] => 20030129222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Liposomal imexon'
[patent_app_type] => new
[patent_app_number] => 09/989695
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32701
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129222.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989695
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989695 | Liposomal imexon | Nov 19, 2001 | Abandoned |